Scott Reuben

Scott S. Reuben ( b. 1959 ) is an American professor of anesthesia and pain management.

Reuben was one of the founders of the concept of multimodal analgesia ( also referred to as preemptive analgesia). This says that the pain management system is to be prevented by early administration of a combination of painkillers before a pain event, such as an operation, an activation and sensitization. Reuben favored primarily active compounds from the group of COX- 2 inhibitors.

In the spring of 2009 ( the IRB approval for a study lacked ) was by chance discovered that Reuben, who worked at Baystate Medical Center in Springfield (Massachusetts ) and researched, had data for his study invented or falsified in a large scale. As a result, 21 of 72 publications of the researcher were identified as fakes since 1996 and withdrawn from the publishing journals. Maybe (Merck, Pfizer, ) promotion plays by pharmaceutical companies, the COX -2 inhibitors produce a role in Reuben's behavior. This largest known fraud scandal in the art anesthesia shook widely trust in research and publishing channels, especially in medicine, but also of science in general.

Reuben was convicted of fraud to six months in prison, $ 50,000 fine and to reimburse more than $ 360,000 to the pharmaceutical companies that had funded his research.

The work of Reuben were also referred to in the evidence- based medical guideline treatment of acute perioperative and posttraumatic pain of the German Interdisciplinary Association of Pain therapy ( four of seven fake cited publications ). This, however, had, according to the authors no effect on core statements of the relevant sections, a distance of cited papers was made.